CR

Ercros SADUS Ercros Stock Report

Last reporting period 30 Jun, 2024

Updated 22 Oct, 2024

Last price

Market cap $B

0.372

Micro

Exchange

XDUS - Boerse Duesseldorf

CRS1.DU Stock Analysis

CR

Avoid

Based on Eyestock quantitative analysis, CRS1.DU`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

44/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-77.1 %

Overvalued

Market cap $B

0.372

Dividend yield

2.43 %

Shares outstanding

94.229 B

Ercros SA engages in the manufacture and commercialization of chemical products. The company is headquartered in Barcelona, Barcelona and currently employs 1,336 full-time employees. The Company’s products are structured into three business lines: Businesses Associated to Chlorine, which comprises the production of chlorine, ethyl acetate, caustic soda, sodium hypochlorite, dichloroethane, chloromethane, sodium chlorate and caustic potash, polyvinyl chloride (PCV), as well as water disinfectants; Intermediate Chemicals, which produces formaldehyde, glues and resins for the fiberboard and plywood industries, and Pharmaceuticals, which comprises raw material and intermediate products used in the pharmaceutical industry. The firm owns such subsidiaries as Marcoating SLU, Gades Ltd and Ercekol AIE, among others. In April 2014, it sold Fosfatos de Cartagena SLU to Timab Iberica.

View Section: Eyestock Rating